Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 28, 2025
Neutrophil store-operated Ca2+ entry: A correctable biomarker of cystic fibrosis lung disease progressionJoe A Wrennall, Matthew Gs Biggart, Charles D Bengtson, et al.The Journal of Clinical Investigation|April 21, 2022
Losartan ameliorates TGF-β1-induced CFTR dysfunction and improves correction by cystic fibrosis modulator therapiesMichael D Kim, Charles D Bengtson, Makoto Yoshida, et al.Journal of Critical Care|July 4, 2017
Stroke volume guided resuscitation in severe sepsis and septic shock improves outcomesHeath E Latham, Charles D Bengtson, Lewis Satterwhite, et al.The European Respiratory Journal|August 1, 2020
Hyperglycaemia in cystic fibrosis adversely affects BK channel function critical for mucus clearanceCharles D Bengtson, Michael D Kim, Abeer Anabtawi, et al.Frontiers in Medicine|March 8, 2021
An Open Label Trial to Assess Safety of Losartan for Treating Worsening Respiratory Illness in COVID-19Charles D Bengtson, Robert N Montgomery, Usman Nazir, et al.Frontiers in Pharmacology|May 20, 2026
Oral losartan yields subtherapeutic airway exposure compared to nebulized delivery and fails to improve mucociliary clearance in cystic fibrosisCharles D Bengtson, Andreas Schmid, Michael D Kim, et al.Medicine|June 19, 2023
Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysisLeon Di Stefano, Malathi Ram, Daniel O Scharfstein, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2026
Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trialJason V Baker, Lianne Siegel, Marcelo Losso, et al.Pageof 1